A detailed history of Severin Investments, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Severin Investments, LLC holds 680 shares of LLY stock, worth $694,756. This represents 0.46% of its overall portfolio holdings.

Number of Shares
680
Previous 571 19.09%
Holding current value
$694,756
Previous $445 Million 16.57%
% of portfolio
0.46%
Previous 0.42%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Dec 03, 2025

BUY
$625.65 - $812.69 $68,195 - $88,583
109 Added 19.09%
680 $519 Million
Q2 2025

Dec 03, 2025

SELL
$713.71 - $898.95 $218,395 - $275,078
-306 Reduced 34.89%
571 $445 Million
Q1 2025

Dec 03, 2025

BUY
$725.72 - $929.72 $157,481 - $201,749
217 Added 32.88%
877 $724 Million
Q4 2024

Dec 03, 2025

BUY
$727.2 - $932.06 $479,952 - $615,159
660 New
660 $509 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $971B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Severin Investments, LLC Portfolio

Follow Severin Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Severin Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Severin Investments, LLC with notifications on news.